figshare
Browse
DATASET
Figure_1.xlsx (70.14 kB)
TEXT
Figure_2A.pzfx (8.12 kB)
DATASET
Figure_2F.xlsx (45.05 kB)
TEXT
Figure_2H-I.pzfx (22.32 kB)
DATASET
Figure_4B-C-D.xlsx (48.68 kB)
DATASET
Figure_4H.xlsx (11.06 kB)
DATASET
Figure_4I-K.xlsx (49.97 kB)
DATASET
Figure_4J.xlsx (11.34 kB)
DATASET
Figure_5.xlsx (76.68 kB)
TEXT
Figure_5D.pzfx (9.54 kB)
TEXT
Figure_5E-F.pzfx (453.15 kB)
TEXT
Figure_5H-J-K.pzfx (59.34 kB)
TEXT
Figure_6D-E.pzfx (20.27 kB)
DATASET
Figure_7B.xlsx (54.84 kB)
DATASET
Figure_7D.xlsx (33.07 kB)
DATASET
Figure_7D_SRSF1.xlsx (43.51 kB)
DATASET
Figure_7G.xlsx (18.69 kB)
DATASET
Figure_7I-J.xlsx (44.31 kB)
DATASET
Figure_7K-L.xlsx (50.46 kB)
DATASET
Figure_3.xls (127.5 kB)
1/0
20 files

MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer

Download all (1.23 MB) This item is shared privately
dataset
modified on 2022-07-20, 08:31

  Vascular Endothelial Growth Factor A (VEGFA) is the most commonly expressed angiogenic growth factor in solid tumors and is generated as multiple isoforms through alternative mRNA splicing. Here, we show that lncRNA MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) and ID4 (inhibitor of DNA-binding 4) protein, previously referred to as regulators of linear isoforms of VEGFA, induce back-splicing of VEGFA exon 7, producing circular RNA circ_0076611. Circ_0076611 is detectable in triple-negative breast cancer (TNBC) cells and tissues, in exosomes released from TNBC cells and in the serum of breast cancer patients. Circ_0076611 interacts with a variety of proliferation-related transcripts, included MYC and VEGFA mRNAs, and increases cell proliferation and migration of TNBC cells. Mechanistically, circ_0076611 favors the expression of its target mRNAs by facilitating their interaction with components of the translation initiation machinery. These results add further complexity to the multiple VEGFA isoforms expressed in cancer cells and highlight the relevance of post-transcriptional regulation of VEGFA expression in TNBC cells.

Funding

The authors received funding from AIRC (Associazione Italiana per la Ricerca sul Cancro) under IG 2018—ID. 21434 project—P.I. Fontemaggi Giulia and under 5xMille 2019–ID. 22759, awarded to G. Blandino.